C
Fresenius Medical Care AG
FMS
$23.98
$0.421.78%
C
Hold
2/26/2025Downgrade
Fresenius Medical Care AG (FMS) was downgraded to C from C+ on 2/26/2025 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.7982 to $0.2345, net income declined 69.55% from $234.2M to $71.31M, and operating cash flow declined 18.11% from $1.08B to $886.57M.
Fresenius Medical Care AG (FMS) was downgraded to C from C+ on 2/26/2025 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.7982 to $0.2345, net income declined 69.55% from $234.2M to $71.31M, and operating cash flow declined 18.11% from $1.08B to $886.57M.
C
Hold
2/12/2025Upgraded
Fresenius Medical Care AG (FMS) was upgraded to C+ from C on 2/12/2025 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 127.34% from $476.2M to $1.08B, earnings per share increased from $0.6861 to $0.7982, and EBIT increased 8.28% from $401.96M to $435.22M.
Fresenius Medical Care AG (FMS) was upgraded to C+ from C on 2/12/2025 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 127.34% from $476.2M to $1.08B, earnings per share increased from $0.6861 to $0.7982, and EBIT increased 8.28% from $401.96M to $435.22M.
C
Hold
10/2/2024Upgraded
Fresenius Medical Care AG (FMS) was upgraded to C from C- on 10/2/2024 due to an increase in the total return index.
Fresenius Medical Care AG (FMS) was upgraded to C from C- on 10/2/2024 due to an increase in the total return index.
C
Hold
8/20/2024Downgrade
Fresenius Medical Care AG (FMS) was downgraded to C- from C on 8/20/2024 due to a decline in the volatility index and total return index.
Fresenius Medical Care AG (FMS) was downgraded to C- from C on 8/20/2024 due to a decline in the volatility index and total return index.
C
Hold
8/5/2024Upgraded
Fresenius Medical Care AG (FMS) was upgraded to C from C- on 8/5/2024 due to a noticeable increase in the growth index, valuation index and volatility index. Operating cash flow increased 244.56% from $138.2M to $476.2M, earnings per share increased from $0.2605 to $0.6861, and EBIT increased 2.43% from $392.42M to $401.96M.
Fresenius Medical Care AG (FMS) was upgraded to C from C- on 8/5/2024 due to a noticeable increase in the growth index, valuation index and volatility index. Operating cash flow increased 244.56% from $138.2M to $476.2M, earnings per share increased from $0.2605 to $0.6861, and EBIT increased 2.43% from $392.42M to $401.96M.
C
Hold
7/8/2024Upgraded
Fresenius Medical Care AG (FMS) was upgraded to C- from D+ on 7/8/2024 due to an increase in the valuation index and volatility index.
Fresenius Medical Care AG (FMS) was upgraded to C- from D+ on 7/8/2024 due to an increase in the valuation index and volatility index.
D
Sell
6/21/2024Downgrade
Fresenius Medical Care AG (FMS) was downgraded to D+ from C- on 6/21/2024 due to a decline in the volatility index.
Fresenius Medical Care AG (FMS) was downgraded to D+ from C- on 6/21/2024 due to a decline in the volatility index.
C
Hold
5/24/2024Upgraded
Fresenius Medical Care AG (FMS) was upgraded to C- from D+ on 5/24/2024 due to an increase in the volatility index.
Fresenius Medical Care AG (FMS) was upgraded to C- from D+ on 5/24/2024 due to an increase in the volatility index.
D
Sell
5/9/2024Downgrade
Fresenius Medical Care AG (FMS) was downgraded to D+ from C- on 5/9/2024 due to a decline in the growth index, dividend index and total return index. Operating cash flow declined 82.15% from $774.13M to $138.2M, earnings per share declined from $0.689 to $0.2605, and EBIT declined 26.41% from $533.25M to $392.42M.
Fresenius Medical Care AG (FMS) was downgraded to D+ from C- on 5/9/2024 due to a decline in the growth index, dividend index and total return index. Operating cash flow declined 82.15% from $774.13M to $138.2M, earnings per share declined from $0.689 to $0.2605, and EBIT declined 26.41% from $533.25M to $392.42M.
C
Hold
3/7/2024Downgrade
Fresenius Medical Care AG (FMS) was downgraded to C- from C on 3/7/2024 due to a decline in the growth index.
Fresenius Medical Care AG (FMS) was downgraded to C- from C on 3/7/2024 due to a decline in the growth index.
C
Hold
2/21/2024Upgraded
Fresenius Medical Care AG (FMS) was upgraded to C from D+ on 2/21/2024 due to an increase in the dividend index, growth index and volatility index. Earnings per share increased from $0.3129 to $0.689, and EBIT increased 50.94% from $396.67M to $598.76M.
Fresenius Medical Care AG (FMS) was upgraded to C from D+ on 2/21/2024 due to an increase in the dividend index, growth index and volatility index. Earnings per share increased from $0.3129 to $0.689, and EBIT increased 50.94% from $396.67M to $598.76M.
D
Sell
10/10/2023Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to D+ from C- on 10/10/2023 due to a decline in the volatility index, total return index and solvency index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to D+ from C- on 10/10/2023 due to a decline in the volatility index, total return index and solvency index.
C
Hold
9/5/2023Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 9/5/2023 due to a decline in the volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 9/5/2023 due to a decline in the volatility index.
C
Hold
8/17/2023Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 8/17/2023 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 615.69% from $153.18M to $1.1B, earnings per share increased from $0.311 to $0.5207, and EBIT increased 34.18% from $260.17M to $349.09M.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 8/17/2023 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 615.69% from $153.18M to $1.1B, earnings per share increased from $0.311 to $0.5207, and EBIT increased 34.18% from $260.17M to $349.09M.
C
Hold
5/17/2023Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 5/17/2023 due to a decline in the valuation index, growth index and dividend index. Operating cash flow declined 75% from $612.7M to $153.18M, EBIT declined 58.28% from $623.56M to $260.17M, and earnings per share declined from $0.4834 to $0.311.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 5/17/2023 due to a decline in the valuation index, growth index and dividend index. Operating cash flow declined 75% from $612.7M to $153.18M, EBIT declined 58.28% from $623.56M to $260.17M, and earnings per share declined from $0.4834 to $0.311.
C
Hold
4/21/2023Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 4/21/2023 due to an increase in the volatility index, total return index and solvency index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 4/21/2023 due to an increase in the volatility index, total return index and solvency index.
C
Hold
2/24/2023Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C- from D+ on 2/24/2023 due to an increase in the dividend index, total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C- from D+ on 2/24/2023 due to an increase in the dividend index, total return index and volatility index.
D
Sell
1/20/2023Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to D+ from D on 1/20/2023 due to an increase in the volatility index and solvency index. The quick ratio increased from 0.7 to 0.8, and debt to equity declined from 0.68 to 0.64.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to D+ from D on 1/20/2023 due to an increase in the volatility index and solvency index. The quick ratio increased from 0.7 to 0.8, and debt to equity declined from 0.68 to 0.64.
D
Sell
10/18/2022Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to D from D+ on 10/18/2022 due to a decline in the total return index, volatility index and efficiency index. Net income declined 11.18% from $176.45M to $156.73M, and total capital declined 1.6% from $30.97B to $30.48B.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to D from D+ on 10/18/2022 due to a decline in the total return index, volatility index and efficiency index. Net income declined 11.18% from $176.45M to $156.73M, and total capital declined 1.6% from $30.97B to $30.48B.
D
Sell
5/11/2022Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to D+ from C- on 5/11/2022 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 76.75% from $765.36M to $177.95M, EBIT declined 33.26% from $566.53M to $378.09M, and earnings per share declined from $0.8925 to $0.6022.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to D+ from C- on 5/11/2022 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 76.75% from $765.36M to $177.95M, EBIT declined 33.26% from $566.53M to $378.09M, and earnings per share declined from $0.8925 to $0.6022.
C
Hold
12/6/2021Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 12/6/2021 due to a decline in the total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 12/6/2021 due to a decline in the total return index and volatility index.
C
Hold
11/4/2021Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 11/4/2021 due to a noticeable increase in the growth index and solvency index. Earnings per share increased from $0.8994 to $1.0961, EBIT increased 17.7% from $484.29M to $569.99M, and debt to equity declined from 0.8 to 0.77.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 11/4/2021 due to a noticeable increase in the growth index and solvency index. Earnings per share increased from $0.8994 to $1.0961, EBIT increased 17.7% from $484.29M to $569.99M, and debt to equity declined from 0.8 to 0.77.
C
Hold
9/15/2021Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 9/15/2021 due to a significant decline in the growth index, total return index and valuation index. Earnings per share declined from $1.0246 to $0.8996, and EBIT declined 10% from $538.21M to $484.4M.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 9/15/2021 due to a significant decline in the growth index, total return index and valuation index. Earnings per share declined from $1.0246 to $0.8996, and EBIT declined 10% from $538.21M to $484.4M.
C
Hold
7/16/2021Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C from C+ on 7/16/2021 due to a decline in the total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C from C+ on 7/16/2021 due to a decline in the total return index.
C
Hold
7/1/2021Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C+ from C on 7/1/2021 due to an increase in the total return index, volatility index and solvency index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C+ from C on 7/1/2021 due to an increase in the total return index, volatility index and solvency index.
C
Hold
10/27/2020Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C from C+ on 10/27/2020 due to a decline in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C from C+ on 10/27/2020 due to a decline in the volatility index and total return index.
C
Hold
10/12/2020Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C+ from C on 10/12/2020 due to an increase in the total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C+ from C on 10/12/2020 due to an increase in the total return index and volatility index.
C
Hold
9/25/2020Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C from C+ on 9/25/2020 due to a decline in the total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C from C+ on 9/25/2020 due to a decline in the total return index.
C
Hold
9/10/2020Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C+ from C on 9/10/2020 due to a noticeable increase in the volatility index, growth index and total return index. Operating cash flow increased 296.62% from $644.15M to $2.55B, EBIT increased 26.7% from $562.9M to $713.19M, and earnings per share increased from $1.0469 to $1.3207.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C+ from C on 9/10/2020 due to a noticeable increase in the volatility index, growth index and total return index. Operating cash flow increased 296.62% from $644.15M to $2.55B, EBIT increased 26.7% from $562.9M to $713.19M, and earnings per share increased from $1.0469 to $1.3207.
C
Hold
1/28/2020Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 1/28/2020 due to a noticeable increase in the growth index, total return index and solvency index. Earnings per share increased from $0.9397 to $1.2233, EBIT increased 16.23% from $547.65M to $636.56M, and debt to equity declined from 0.81 to 0.8.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 1/28/2020 due to a noticeable increase in the growth index, total return index and solvency index. Earnings per share increased from $0.9397 to $1.2233, EBIT increased 16.23% from $547.65M to $636.56M, and debt to equity declined from 0.81 to 0.8.
C
Hold
8/1/2019Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 8/1/2019 due to a noticeable decline in the growth index, valuation index and solvency index. EBIT declined 6.66% from $586.74M to $547.65M, earnings per share declined from $0.9996 to $0.9397, and the quick ratio declined from 0.67 to 0.63.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 8/1/2019 due to a noticeable decline in the growth index, valuation index and solvency index. EBIT declined 6.66% from $586.74M to $547.65M, earnings per share declined from $0.9996 to $0.9397, and the quick ratio declined from 0.67 to 0.63.
C
Hold
7/24/2019Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 7/24/2019 due to an increase in the volatility index and valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 7/24/2019 due to an increase in the volatility index and valuation index.
C
Hold
7/9/2019Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 7/9/2019 due to a decline in the volatility index and valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 7/9/2019 due to a decline in the volatility index and valuation index.
C
Hold
6/20/2019Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 6/20/2019 due to an increase in the volatility index and valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 6/20/2019 due to an increase in the volatility index and valuation index.
C
Hold
5/7/2019Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 5/7/2019 due to a large decline in the growth index, dividend index and solvency index. Operating cash flow declined 91.07% from $960.69M to $85.83M, debt to equity increased from 0.64 to 1.11, and earnings per share declined from $1.5768 to $0.9996.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 5/7/2019 due to a large decline in the growth index, dividend index and solvency index. Operating cash flow declined 91.07% from $960.69M to $85.83M, debt to equity increased from 0.64 to 1.11, and earnings per share declined from $1.5768 to $0.9996.
C
Hold
4/17/2019Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 4/17/2019 due to an increase in the total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C from C- on 4/17/2019 due to an increase in the total return index and volatility index.
C
Hold
2/25/2019Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C- from D+ on 2/25/2019 due to a substantial increase in the growth index, dividend index and efficiency index. Net income increased 46.5% from $330.97M to $484.87M, earnings per share increased from $1.0799 to $1.5768, and operating cash flow increased 35.55% from $708.72M to $960.69M.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to C- from D+ on 2/25/2019 due to a substantial increase in the growth index, dividend index and efficiency index. Net income increased 46.5% from $330.97M to $484.87M, earnings per share increased from $1.0799 to $1.5768, and operating cash flow increased 35.55% from $708.72M to $960.69M.
D
Sell
2/19/2019Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to D+ from C- on 2/19/2019 due to a decline in the total return index, volatility index and valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to D+ from C- on 2/19/2019 due to a decline in the total return index, volatility index and valuation index.
C
Hold
1/3/2019Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 1/3/2019 due to a noticeable decline in the total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C- from C on 1/3/2019 due to a noticeable decline in the total return index and volatility index.
C
Hold
11/14/2018Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C from C+ on 11/14/2018 due to a substantial decline in the growth index, volatility index and total return index. Earnings per share declined from $3.8522 to $1.0799, EBIT declined 11.78% from $657.64M to $580.2M, and operating cash flow declined 9.36% from $781.95M to $708.72M.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C from C+ on 11/14/2018 due to a substantial decline in the growth index, volatility index and total return index. Earnings per share declined from $3.8522 to $1.0799, EBIT declined 11.78% from $657.64M to $580.2M, and operating cash flow declined 9.36% from $781.95M to $708.72M.
C
Hold
10/24/2018Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 10/24/2018 due to a decline in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 10/24/2018 due to a decline in the volatility index and total return index.
B
Buy
10/17/2018Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 10/17/2018 due to a large decline in the total return index, volatility index and growth index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 10/17/2018 due to a large decline in the total return index, volatility index and growth index.
B
Buy
12/18/2017Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from B+ on 12/18/2017 due to a decline in the valuation index, solvency index and total return index. The quick ratio declined from 0.75 to 0.74.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from B+ on 12/18/2017 due to a decline in the valuation index, solvency index and total return index. The quick ratio declined from 0.75 to 0.74.
B
Buy
7/17/2017Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 7/17/2017 due to a large increase in the total return index, volatility index and efficiency index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 7/17/2017 due to a large increase in the total return index, volatility index and efficiency index.
B
Buy
2/28/2017Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 2/28/2017 due to an increase in the volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 2/28/2017 due to an increase in the volatility index.
B
Buy
2/24/2017Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 2/24/2017 due to a significant increase in the growth index, dividend index and valuation index. Operating cash flow increased 92.21% from $438.87M to $843.57M, EBIT increased 22.08% from $640.91M to $782.43M, and earnings per share increased from $1.0889 to $1.2676.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 2/24/2017 due to a significant increase in the growth index, dividend index and valuation index. Operating cash flow increased 92.21% from $438.87M to $843.57M, EBIT increased 22.08% from $640.91M to $782.43M, and earnings per share increased from $1.0889 to $1.2676.
C
Hold
2/13/2017Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 2/13/2017 due to a decline in the volatility index and valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 2/13/2017 due to a decline in the volatility index and valuation index.
B
Buy
1/26/2017Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 1/26/2017 due to a major increase in the valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 1/26/2017 due to a major increase in the valuation index.
C
Hold
1/6/2017Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 1/6/2017 due to a decline in the total return index, volatility index and valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 1/6/2017 due to a decline in the total return index, volatility index and valuation index.
B
Buy
12/22/2016Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 12/22/2016 due to an increase in the volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 12/22/2016 due to an increase in the volatility index.
C
Hold
11/23/2016Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 11/23/2016 due to a decline in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 11/23/2016 due to a decline in the volatility index and total return index.
B
Buy
11/22/2016Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 11/22/2016 due to a significant decline in the growth index, volatility index and total return index. Operating cash flow declined 35.24% from $677.65M to $438.87M.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 11/22/2016 due to a significant decline in the growth index, volatility index and total return index. Operating cash flow declined 35.24% from $677.65M to $438.87M.
B
Buy
10/17/2016Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from B+ on 10/17/2016 due to a large decline in the total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from B+ on 10/17/2016 due to a large decline in the total return index and volatility index.
B
Buy
10/4/2016Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B+ from A- on 10/4/2016 due to a decline in the total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B+ from A- on 10/4/2016 due to a decline in the total return index.
A
Buy
9/6/2016Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A- from B+ on 9/6/2016 due to an increase in the total return index, volatility index and valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A- from B+ on 9/6/2016 due to an increase in the total return index, volatility index and valuation index.
B
Buy
8/4/2016Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 8/4/2016 due to a significant increase in the growth index, valuation index and volatility index. Operating cash flow increased 276.89% from $179.8M to $677.65M, earnings per share increased from $0.3734 to $0.48, and EBIT increased 20.3% from $521.72M to $627.62M.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 8/4/2016 due to a significant increase in the growth index, valuation index and volatility index. Operating cash flow increased 276.89% from $179.8M to $677.65M, earnings per share increased from $0.3734 to $0.48, and EBIT increased 20.3% from $521.72M to $627.62M.
B
Buy
5/5/2016Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from A- on 5/5/2016 due to a substantial decline in the growth index, dividend index and solvency index. Operating cash flow declined 67.21% from $548.32M to $179.8M, earnings per share declined from $0.5191 to $0.3734, and EBIT declined 20.03% from $652.43M to $521.72M.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from A- on 5/5/2016 due to a substantial decline in the growth index, dividend index and solvency index. Operating cash flow declined 67.21% from $548.32M to $179.8M, earnings per share declined from $0.5191 to $0.3734, and EBIT declined 20.03% from $652.43M to $521.72M.
A
Buy
5/2/2016Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A- from B+ on 5/2/2016 due to a large increase in the total return index and solvency index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A- from B+ on 5/2/2016 due to a large increase in the total return index and solvency index.
B
Buy
3/1/2016Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 3/1/2016 due to an increase in the dividend index, total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 3/1/2016 due to an increase in the dividend index, total return index and volatility index.
B
Buy
2/18/2016Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from B+ on 2/18/2016 due to a decline in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from B+ on 2/18/2016 due to a decline in the volatility index and total return index.
B
Buy
2/3/2016Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 2/3/2016 due to a large increase in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 2/3/2016 due to a large increase in the volatility index and total return index.
B
Buy
11/27/2015Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 11/27/2015 due to an increase in the volatility index and valuation index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 11/27/2015 due to an increase in the volatility index and valuation index.
B
Buy
11/9/2015Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 11/9/2015 due to a decline in the growth index, valuation index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 11/9/2015 due to a decline in the growth index, valuation index and volatility index.
B
Buy
10/26/2015Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 10/26/2015 due to an increase in the volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 10/26/2015 due to an increase in the volatility index.
B
Buy
9/18/2015Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 9/18/2015 due to a substantial decline in the volatility index, total return index and efficiency index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 9/18/2015 due to a substantial decline in the volatility index, total return index and efficiency index.
B
Buy
6/12/2015Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from B+ on 6/12/2015 due to a major decline in the valuation index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B from B+ on 6/12/2015 due to a major decline in the valuation index and total return index.
B
Buy
6/4/2015Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B+ from A- on 6/4/2015 due to a decline in the volatility index, valuation index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B+ from A- on 6/4/2015 due to a decline in the volatility index, valuation index and total return index.
A
Buy
5/20/2015Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A- from B+ on 5/20/2015 due to an increase in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A- from B+ on 5/20/2015 due to an increase in the volatility index and total return index.
B
Buy
5/5/2015Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B+ from A- on 5/5/2015 due to a decline in the volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B+ from A- on 5/5/2015 due to a decline in the volatility index.
A
Buy
5/1/2015Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to A- from A on 5/1/2015 due to a substantial decline in the growth index, dividend index and efficiency index. Net income declined 37.51% from $335.32M to $209.55M, earnings per share declined from $1.1018 to $0.69, and EBIT declined 24.42% from $659.18M to $498.2M.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to A- from A on 5/1/2015 due to a substantial decline in the growth index, dividend index and efficiency index. Net income declined 37.51% from $335.32M to $209.55M, earnings per share declined from $1.1018 to $0.69, and EBIT declined 24.42% from $659.18M to $498.2M.
A
Buy
4/10/2015Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A from A- on 4/10/2015 due to a noticeable increase in the volatility index, total return index and solvency index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A from A- on 4/10/2015 due to a noticeable increase in the volatility index, total return index and solvency index.
A
Buy
3/2/2015Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A- from B+ on 3/2/2015 due to an increase in the dividend index, total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to A- from B+ on 3/2/2015 due to an increase in the dividend index, total return index and volatility index.
B
Buy
2/25/2015Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 2/25/2015 due to a noticeable increase in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B+ from B on 2/25/2015 due to a noticeable increase in the volatility index and total return index.
B
Buy
12/1/2014Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 12/1/2014 due to an increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.97 to 0.96.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 12/1/2014 due to an increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.97 to 0.96.
B
Buy
10/30/2014Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 10/30/2014 due to an increase in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 10/30/2014 due to an increase in the volatility index and total return index.
C
Hold
10/15/2014Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 10/15/2014 due to a decline in the total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 10/15/2014 due to a decline in the total return index.
B
Buy
9/30/2014Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 9/30/2014 due to a significant increase in the growth index and total return index. Operating cash flow increased 300.12% from $112.29M to $449.31M, EBIT increased 27.22% from $432.37M to $550.08M, and earnings per share increased from $0.68 to $0.77.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B- from C+ on 9/30/2014 due to a significant increase in the growth index and total return index. Operating cash flow increased 300.12% from $112.29M to $449.31M, EBIT increased 27.22% from $432.37M to $550.08M, and earnings per share increased from $0.68 to $0.77.
C
Hold
5/9/2014Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 5/9/2014 due to a large decline in the growth index, dividend index and total return index. Operating cash flow declined 80.93% from $588.79M to $112.29M, earnings per share declined from $1.159 to $0.68, and EBIT declined 33.46% from $649.77M to $432.37M.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to C+ from B- on 5/9/2014 due to a large decline in the growth index, dividend index and total return index. Operating cash flow declined 80.93% from $588.79M to $112.29M, earnings per share declined from $1.159 to $0.68, and EBIT declined 33.46% from $649.77M to $432.37M.
B
Buy
5/5/2014Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 5/5/2014 due to a decline in the total return index and volatility index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 5/5/2014 due to a decline in the total return index and volatility index.
B
Buy
3/28/2014Upgraded
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 3/28/2014 due to an increase in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was upgraded to B from B- on 3/28/2014 due to an increase in the volatility index and total return index.
B
Buy
3/13/2014Downgrade
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 3/13/2014 due to a decline in the volatility index and total return index.
Fresenius Medical Care AG & Co. KGAA (FMS) was downgraded to B- from B on 3/13/2014 due to a decline in the volatility index and total return index.
NYSE
03/07/2025 4:00PM Eastern
Quotes delayed
